In melanoma patients, the median transcript levels of genes expressed in sensory nerves [Nav1.8, TRPV1 and vasoactive intestinal peptide (VIP)] were used to stratify 21437 patient tumour transcriptomes into high and low expression for each gene. This evidence concerns the gene SCN10A and neoplasm.